logo
Select company
Select metric
-2427.19%EBIT Margin
VS
Market
4
Sector
13
Industry
24
History
-
$ 2.49Close
$ 0.73 - $ 2.79 52-Week Range
Ticker Information

Ticker

CRBU

Company Name

CARIBOU BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARIBOU BIOSCIENCES INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRBU - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -164.27M-2427.19%$ 6.77M
3/31/2025$ -147.87M-1954.67%$ 7.57M
12/31/2024$ -149.11M-1492.04%$ 9.99M
9/30/2024$ -147.93M-1289.12%$ 11.47M
6/30/2024$ -123.25M-372.2%$ 33.11M
3/31/2024$ -115.07M-344.47%$ 33.4M
12/31/2023$ -101.88M-295.49%$ 34.48M
9/30/2023$ -94.48M-272.99%$ 34.61M
6/30/2023$ -111.13M-779.74%$ 14.25M
3/31/2023$ -108.31M-737.33%$ 14.69M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARIBOU BIOSCIENCES INC's latest trailing twelve months (TTM) EBIT % stands at -292.1%.
  • Over the past 5 years, CARIBOU BIOSCIENCES INC's average EBIT % has been -855.89%.
  • The median EBIT % for CARIBOU BIOSCIENCES INC during this period was -703.06%
  • CARIBOU BIOSCIENCES INC reached its highest EBIT % over the past 5 years at -272.99%.
  • The lowest EBIT % recorded by CARIBOU BIOSCIENCES INC in the same timeframe -2427.19%

CARIBOU BIOSCIENCES INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
KRRO : KORRO BIO INC -1452.95%TVRD : TVARDI THERAPEUTICS INC -210.4%TCRX : TSCAN THERAPEUTICS INC -1920.2%ACOG : ALPHA COGNITION INC -434.42%CRVO : CERVOMED INC -290.75%FATE : FATE THERAPEUTICS INC -2025.05%OVID : OVID THERAPEUTICS INC -574.02%OBIO : ORCHESTRA BIOMED HOLDINGS INC -2366.27%VERU : VERU INC -482.04%CBUS : CIBUS INC -4975.71%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for CARIBOU BIOSCIENCES INC is calculated as follows: EBIT [ $ -36.11M ] / Revenues [ $ 12.36M ]
(=) EBIT % [ -292.1% ]

CRBU - EBIT Margin, Last 5 years

-2427.19%

Minimum

Jun 30, 2025

-272.99%

Maximum

Sep 30, 2023

-855.89%

Average

-703.06%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%